|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase I clinical trial of histone deacetylase inhibitors suberoylanilide hydroxamic acid administered intravenously显示文摘 | KELLY WK RICHON WN O'CONNOR O | 2003 | Clin Cancer Res2003，9，10： | 1 |
| 2 | Epothilones: tubulin polymerization as a novel target for prostate cancer therapy显示文摘 | LEE JJ KELLY WK | 2009 | Nat Clin Pract Oncol2009，6，2： | 1 |
| 3 | Conservative management of stage I endometrial carcinoma after surgical staging显示文摘 | Strughn JMJr Huh WK Kelly FJ | 2002 | Gynecol Oncol2002，84，： | 1 |
| 4 | Phase Ⅰ clinical trial of histone deacetylase inhibitor: suberoy lanilide hydroxamic acid administered intravenously显示文摘 | Kelly WK Richon VM Connor O | 2003 | Clin Cancer Res2003，9，10： | 1 |
| 5 | Histone deacetylase inhibitors: from target to clinical trials显示文摘 | O'Connor OA Marks PA | 2002 | Expert Opin Investig Drugs2002，11，12： | 1 |
| 6 | Phase Ⅰ clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously显示文摘 | KELLY WK RICHON VM O'CONNOR O | 2003 | Clin Cancer Res2003，9，101： | 1 |
| 7 | Phase I study of an oral histone deacetylase inhibitor,suberoylanilide hydroxamic acid,in patients with advanced cancer显示文摘 | Kelly WK O'Connor OA Krug LM | 2005 | J Clin Oncol2005，23，17： | 1 |
| 8 | Randomized, Double-Blind, Placebo-Controlled Phase Ill Trial Comparing Do- eetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401 显示文摘 | KELLY WK HALABI S CARDUCCI M | 2012 | J Clin Oneol2012，30，13： | 1 |
| 9 | An open-label, multicenter, phase Ⅶ study of single-agent AT-101 in men with castrate-resist- ant prostate cancer显示文摘 | Liu G Kelly WK Wilding G | 2009 | Clin Cancer Res2009，15，9： | 1 |
| 10 | Epothilones: tubulin polymerization as a novel target for prostate cancer therapy显示文摘 | Lee J J Kelly WK | 2008 | Nat Clin Pract Oncol2008，6，2： | 1 |
| 11 | Updated prognostic model for predicting overall survival in first-line chemotherapy for pa- tients with metastatic castration-resistant prostate cancer显示文摘 | Halabi S Lin CY Kelly WK | 2014 | J Clin 0ncol2014，32，67： | 1 |
| 12 | Drug insight: Histone deacetylase inhibitors-development of the new targeted anticancer agent suberoylanilide hydroxamic acid显示文摘 | Kelly WK Marks PA | 2005 | Nat Clin Pract Oncol2005，2，3： | 1 |
| 13 | Randomized,double-blind,placebo-controlled phase Ⅲ trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer:CALGB 90401显示文摘 | Kelly WK Halabi S Carducci M | | 0，，13： | 1 |
| 14 | PhaseⅠclinical trial of histone deacetylase inhibitors suberoylanilide hydroxamic acid administered intravenously显示文摘 | Kelly WK Richon VM O'Connor O | 2003 | Clin Lin Cancer Res2003，9，10： | 1 |
| 15 | An open-label, multicenter, phase I/I] study of single-agent AT-t01 in men with castrate-resistant prostate cancer 显示文摘 | Liu G Kelly WK Wilding G | 2009 | Clin Cancer Res2009，15，9： | 1 |
| 16 | Histone deacetyIases and cancer: causes and therapies显示文摘 | Marks P Rifkind RA Richon VM BresIow R Miller T Kelly WK | 2001 | Nat Rev Cancer2001，1，3： | 1 |
| 17 | Phase I Clinical Trial of Histone Deaeetylase Inhibitor Suberoylanilide Hydroxamic Acid Administered Intravenously显示文摘 | KELLY WK RICHON WM O'CONNOR O | 2003 | Clin Lin Canc- er Res2003，9，10： | 1 |
| 18 | Outsmarting androgen receptor: creative ap- proaches for targeting aberrant androgen signaling in advanced prostate cancer显示文摘 | Krtudsen KE Kelly WK | 2011 | Expert Rev Endocrinol Metab2011，6，3： | 1 |
| 19 | A randomized,double-blind,placebo-controlled phase Ⅲ trial comparing docetaxel,preunisone,and placebo with docetaxel,prednisone,and beracizumab in men with metastatic castration-resistant prostate cancer Cm(RPC):Survival results of CALGB90401显示文摘 | Kelly WK Halabi S Carducci MA | 2010 | J Din Oncol2010，28，： | 1 |
| 20 | Multi-institutional trial of the epothilone B analogue BMS-247550 with or without estramustine phosphate(EMP) in patients with progressive castrate-metastatic prostate cancer(PCMPC):Updated results显示文摘 | Kelly WK Galsky MD Small EJ | 2004 | Proc Am Soc Clin Oncol2004，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员